Insulin pricing: could an e-commerce approach cut costs? (with abstract)
Article published by [[Other sources |Pharmaceutical technology]] and reviewed by Nikolay Sidelnikov
| Insulin pricing: could an e-commerce approach cut costs? (with abstract) | |
|---|---|
| Published By | [[Pharmaceutical technology]] |
| Publish Date | March, 2022 |
| Authors | William Newton |
| Topics | B2B eCommerce in Pharma, D2C |
| Statistics | |
| Article Size | words |
| Diagrams | No |
| Downloadable Version | No |
| Reviewers | |
| Page Owner | Nikolay Sidelnikov |
| Summary Author | Nikolay Sidelnikov |
Abstract
The short article Insulin pricing: could an e-commerce approach cut costs? was published by Pharmaceutical Technology in 2023. This article provides a good illustration of direct-to-consumer (D2C) trend which the industry is experimenting with in search of new business models. We will definitely see more experiments in the future.
Quote
Recently, several high-profile companies have promised to upend the healthcare model and deliver generic drugs and biosimilars directly to consumers. Under these models, patients with or without insurance can fill the prescriptions they receive from their healthcare providers.